TYK269

From PedsAnesthesiaNet
Revision as of 02:34, 5 March 2021 by WikiSysop (talk | contribs) (1 revision imported)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Use of proton pump inhibitors for treatment of GERD in preterm infants is associated with:

a) Increased gastric acidity

b) Reduced duration of acid exposure

c) Decreases morbidity

d) Decreased incidence of intraventricular hemorrhage

Click for Answer

Answer

Answer b. PPIs act by irreversible inhibition of H+/K+-ATPase in the parietal cells thus decreasing the amount of hydrogen ions secreted. Although widely used, there is limited data to suggest that acid suppression has any short or long term morbidity benefits in preterm infants with GER. Studies have shown that PPI reduces gastric acidity and the duration of acid exposure in preterm infants group. Unfortunately, gastric acid suppression has been associated with potential adverse side effects including necrotizing enterocolitis, altered gastric colonization, and intraventricular hemorrhage.

Notes

This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.

Keywords



<Prev Question --- Next Question>

About Test Your Knowledge